A director at LifeStance Health Group, Inc. (NASDAQ:LFST) sold common stock totaling approximately $4.61 million on May 12, 2026.
The sale involved 575,034 shares. Of these, 287,517 were sold indirectly through Vitthal LLC and 287,517 through Shama LLC.
The sale comes as LFST stock declined 8.5% over the past week, though shares are up 41% over the past year and 27% over six months.
Following the sale, the director holds 986,931 shares through Vitthal LLC, 1,103,729 through Shama LLC, 57,619 directly, and 36,363 through Alpine Glow Capital.
Analysts suggest the stock appears undervalued. The company remains profitable with continued growth expected.
